XRAY
DENTSPLY SIRONA Inc. NASDAQ Listed Aug 12, 1987$10.96
After hrs
$11.05
+0.45%
Mkt Cap $2.2B
52w Low $9.85
15.1% of range
52w High $17.18
50d MA $12.07
200d MA $12.55
P/E (TTM)
-3.9x
EV/EBITDA
-96.1x
P/B
1.8x
Debt/Equity
1.8x
ROE
-44.7%
P/FCF
21.9x
RSI (14)
—
ATR (14)
—
Beta
1.00
50d MA
$12.07
200d MA
$12.55
Avg Volume
4.5M
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
13320 Ballantyne Corporate Place · Charlotte, NC 28277-3607 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 0.28 | 0.27 | -3.6% | 11.37 | -0.1% | -2.0% | -3.6% | — | — | — | — |
| Feb 26, 2026 | AMC | 0.28 | 0.27 | -3.6% | 12.71 | +2.7% | +15.5% | +12.6% | +4.6% | +5.7% | +4.9% | — |
| Nov 6, 2025 | AMC | 0.45 | 0.37 | -17.8% | 11.02 | -1.8% | +1.5% | -0.2% | -0.4% | -1.6% | -0.6% | — |
| Aug 7, 2025 | AMC | 0.50 | 0.52 | +4.0% | 13.23 | -0.8% | -2.0% | -5.3% | -1.4% | +4.7% | +4.8% | — |
| May 8, 2025 | AMC | 0.29 | 0.43 | +48.3% | 15.91 | -0.4% | -0.6% | +5.3% | +4.3% | +3.4% | +3.7% | — |
| Feb 27, 2025 | AMC | 0.47 | 0.26 | -44.7% | 17.15 | +0.0% | -3.5% | -6.8% | -9.1% | -5.8% | -5.2% | — |
| Nov 7, 2024 | AMC | 0.48 | 0.50 | +4.2% | 17.26 | +1.9% | +3.5% | +2.3% | +3.0% | +0.5% | +3.5% | — |
| Jul 31, 2024 | AMC | 0.50 | 0.49 | -2.0% | 27.14 | +0.4% | -1.5% | -6.1% | -9.8% | -11.0% | -12.9% | — |
| May 2, 2024 | AMC | 0.42 | 0.42 | +0.0% | 28.38 | +1.3% | -0.3% | -0.5% | -0.5% | -2.0% | -0.6% | — |
| Feb 29, 2024 | AMC | 0.43 | 0.44 | +2.3% | 32.68 | +0.9% | +1.8% | +1.8% | +1.8% | +2.2% | +2.3% | — |
| Nov 2, 2023 | AMC | 0.48 | 0.49 | +2.1% | 28.54 | +0.8% | +2.3% | +0.1% | -0.5% | -3.0% | -4.5% | — |
| Aug 7, 2023 | AMC | — | -0.09 | — | 39.49 | -0.8% | -0.3% | -2.6% | -2.4% | -1.7% | -3.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2 | Barrington Research | Maintains | Outperform → Outperform | — | $14.68 | $14.39 | -2.0% | -2.5% | -9.4% | -8.4% | -9.2% | -13.2% |
| Mar 2 | Mizuho | Maintains | Neutral → Neutral | — | $14.68 | $14.39 | -2.0% | -2.5% | -9.4% | -8.4% | -9.2% | -13.2% |
| Feb 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $12.71 | $13.05 | +2.7% | +15.5% | +12.6% | +4.6% | +5.7% | +4.9% |
| Feb 27 | Baird | Maintains | Neutral → Neutral | — | $12.71 | $13.05 | +2.7% | +15.5% | +12.6% | +4.6% | +5.7% | +4.9% |
| Feb 27 | Evercore ISI | Maintains | In Line → In Line | — | $12.71 | $13.05 | +2.7% | +15.5% | +12.6% | +4.6% | +5.7% | +4.9% |
| Feb 19 | BofA Securities | Upgrade | Neutral → Buy | — | $12.49 | $13.12 | +5.0% | +0.2% | +0.4% | +0.5% | +5.2% | +2.5% |
| Feb 3 | UBS | Maintains | Buy → Buy | — | $12.21 | $12.18 | -0.2% | -1.7% | +2.7% | +2.6% | +12.7% | +12.2% |
| Jan 20 | Mizuho | Maintains | Neutral → Neutral | — | $12.21 | $12.00 | -1.7% | -1.3% | +4.3% | +6.5% | +4.3% | +4.2% |
| Jan 5 | Barrington Research | Maintains | Outperform → Outperform | — | $11.27 | $11.30 | +0.3% | +3.0% | +9.8% | +9.8% | +10.7% | +13.4% |
| Dec 16 | Barrington Research | Maintains | Outperform → Outperform | — | $11.40 | $11.35 | -0.4% | -0.3% | +0.3% | -1.1% | -1.7% | -1.2% |
| Dec 16 | Baird | Maintains | Neutral → Neutral | — | $11.40 | $11.35 | -0.4% | -0.3% | +0.3% | -1.1% | -1.7% | -1.2% |
| Nov 10 | Barrington Research | Maintains | Outperform → Outperform | — | $11.18 | $11.21 | +0.3% | -1.6% | -1.8% | -3.0% | -2.1% | -5.9% |
| Nov 7 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $11.02 | $10.82 | -1.8% | +1.5% | -0.2% | -0.4% | -1.6% | -0.6% |
| Nov 7 | William Blair | Downgrade | Outperform → Market Perform | — | $11.02 | $10.82 | -1.8% | +1.5% | -0.2% | -0.4% | -1.6% | -0.6% |
| Nov 7 | JP Morgan | Maintains | Neutral → Neutral | — | $11.02 | $10.82 | -1.8% | +1.5% | -0.2% | -0.4% | -1.6% | -0.6% |
| Oct 29 | Barrington Research | Maintains | Outperform → Outperform | — | $13.07 | $13.08 | +0.1% | -1.6% | -3.7% | -3.5% | -4.0% | -4.4% |
| Oct 28 | UBS | Maintains | Buy → Buy | — | $13.09 | $13.01 | -0.6% | -0.2% | -1.8% | -3.8% | -3.7% | -4.1% |
| Oct 8 | Evercore ISI | Maintains | In Line → In Line | — | $12.33 | $12.29 | -0.3% | +0.4% | -0.9% | -4.1% | -1.0% | +1.1% |
| Sep 26 | Needham | Maintains | Hold → Hold | — | $12.37 | $12.23 | -1.1% | +1.1% | +1.9% | +2.6% | +4.7% | +4.8% |
| Aug 8 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $13.23 | $13.13 | -0.8% | -2.0% | -5.3% | -1.4% | +4.7% | +4.8% |
| Aug 8 | UBS | Maintains | Buy → Buy | — | $13.23 | $13.13 | -0.8% | -2.0% | -5.3% | -1.4% | +4.7% | +4.8% |
| Aug 8 | Barrington Research | Maintains | Outperform → Outperform | — | $13.23 | $13.13 | -0.8% | -2.0% | -5.3% | -1.4% | +4.7% | +4.8% |
| Aug 8 | Stifel | Maintains | Hold → Hold | — | $13.23 | $13.13 | -0.8% | -2.0% | -5.3% | -1.4% | +4.7% | +4.8% |
| Jul 22 | Barrington Research | Maintains | Outperform → Outperform | — | $15.63 | $15.68 | +0.3% | +5.0% | +7.8% | +5.3% | +2.6% | +2.8% |
| Jul 21 | Needham | Maintains | Hold → Hold | — | $15.68 | $16.16 | +3.1% | -0.3% | +4.7% | +7.5% | +5.0% | +2.2% |
| May 12 | Barrington Research | Maintains | Outperform → Outperform | — | $15.81 | $16.57 | +4.8% | +5.9% | +5.0% | +4.0% | +4.4% | +5.6% |
| May 9 | UBS | Maintains | Buy → Buy | — | $15.91 | $15.84 | -0.4% | -0.6% | +5.3% | +4.3% | +3.4% | +3.7% |
| Apr 30 | Piper Sandler | Maintains | Neutral → Neutral | — | $13.95 | $13.82 | -0.9% | -0.4% | -0.1% | +0.9% | -0.8% | -4.2% |
| Mar 13 | Mizuho | Maintains | Neutral → Neutral | — | $15.33 | $15.07 | -1.7% | -2.2% | +1.5% | +1.7% | +2.7% | +2.2% |
| Mar 13 | Needham | Downgrade | Buy → Hold | — | $15.33 | $15.07 | -1.7% | -2.2% | +1.5% | +1.7% | +2.7% | +2.2% |
| Feb 28 | Barrington Research | Maintains | Outperform → Outperform | — | $17.15 | $17.15 | +0.0% | -3.5% | -6.8% | -9.1% | -5.8% | -5.2% |
| Feb 28 | Needham | Maintains | Buy → Buy | — | $17.15 | $17.15 | +0.0% | -3.5% | -6.8% | -9.1% | -5.8% | -5.2% |
| Feb 28 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $17.15 | $17.15 | +0.0% | -3.5% | -6.8% | -9.1% | -5.8% | -5.2% |
| Feb 28 | Baird | Maintains | Neutral → Neutral | — | $17.15 | $17.15 | +0.0% | -3.5% | -6.8% | -9.1% | -5.8% | -5.2% |
| Feb 11 | Needham | Maintains | Buy → Buy | — | $18.46 | $18.38 | -0.4% | -1.0% | -0.5% | +1.7% | -0.8% | +2.1% |
| Jan 30 | Needham | Maintains | Buy → Buy | — | $19.63 | $19.98 | +1.8% | +3.5% | +0.7% | -1.4% | -1.7% | -1.7% |
| Jan 23 | Jefferies | Downgrade | Buy → Hold | — | $19.36 | $19.19 | -0.9% | +0.4% | +0.9% | +1.3% | +1.3% | +1.4% |
| Jan 7 | Evercore ISI | Downgrade | Outperform → In Line | — | $18.86 | $18.69 | -0.9% | -1.3% | -0.1% | -3.9% | -1.1% | -4.2% |
| Dec 17 | Morgan Stanley | Maintains | Overweight → Overweight | — | $19.59 | $19.39 | -1.0% | -2.0% | -4.6% | -5.7% | -4.5% | -3.3% |
| Dec 3 | UBS | Maintains | Buy → Buy | — | $19.82 | $19.61 | -1.1% | -2.2% | -1.8% | -2.6% | -3.7% | -1.9% |
| Nov 8 | Barrington Research | Maintains | Outperform → Outperform | — | $17.26 | $17.59 | +1.9% | +3.5% | +2.3% | +3.0% | +0.5% | +3.5% |
| Nov 8 | Baird | Maintains | Neutral → Neutral | — | $17.26 | $17.59 | +1.9% | +3.5% | +2.3% | +3.0% | +0.5% | +3.5% |
| Nov 7 | Leerink Partners | Downgrade | Outperform → Market Perform | — | $23.98 | $19.20 | -19.9% | -28.0% | -25.5% | -26.4% | -25.9% | -27.6% |
| Oct 28 | Needham | Maintains | Buy → Buy | — | $23.31 | $23.52 | +0.9% | +1.3% | -0.3% | +0.4% | -0.6% | +0.8% |
| Oct 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $24.48 | $24.33 | -0.6% | +0.0% | +0.2% | -0.2% | +0.2% | -0.2% |
| Sep 20 | Barrington Research | Maintains | Outperform → Outperform | — | $26.90 | $26.76 | -0.5% | -2.3% | -2.7% | -3.0% | -4.3% | -1.4% |
| Aug 20 | Needham | Maintains | Buy → Buy | — | $25.54 | $24.82 | -2.8% | -4.8% | -3.7% | -5.5% | -0.9% | -1.0% |
| Jul 31 | Needham | Maintains | Buy → Buy | — | $26.78 | $26.45 | -1.2% | +1.3% | -0.2% | -4.8% | -8.6% | -9.8% |
| Jul 22 | Baird | Maintains | Neutral → Neutral | — | $26.36 | $26.36 | +0.0% | +0.1% | -1.1% | -0.5% | +0.3% | +0.2% |
| Jul 18 | Stifel | Maintains | Hold → Hold | — | $27.54 | $27.15 | -1.4% | -4.1% | -4.3% | -4.2% | -5.4% | -4.7% |
No insider trades available.
8-K · 2.02
!! High
DENTSPLY SIRONA Inc. -- 8-K 2.02: Earnings Results
DENTSPLY SIRONA reported Q1 2026 earnings results on May 5, providing updated financial metrics and non-GAAP reconciliations for investor assessment of operational performance.
May 5
8-K
DENTSPLY SIRONA Inc. -- 8-K Filing
DENTSPLY SIRONA strengthened its board with three experienced executives from dental and financial sectors, including Morgan Stanley's former investment banking leader and IDEXX's ex-CFO, signaling potential strategic shifts ahead.
Feb 26
8-K · 5.02
!!! Very High
DENTSPLY SIRONA Inc. -- 8-K 5.02: Executive Change
DENTSPLY SIRONA appointed James D. Forbes as director while Willie A. Deese resigned, signaling potential strategic shifts in board composition and governance priorities.
Feb 24
8-K · 5.02
!!! Very High
Charles River Laboratories International, Inc. -- 8-K 5.02: Executive Change
Charles River Laboratories appointed Glenn Coleman as Corporate Executive Vice President and Chief Financial Officer, effective April 6, 2026, signaling leadership stability in financial operations.
Feb 18
Data updated apr 27, 2026 10:52am
· Source: massive.com